Comparison of Two-versus Three-Dimensional Treatment Planning for Patients Receiving Chest Radiotherapy for Symptom Control
18 Years
N/A
Both
Non-small Cell Lung Cancer
Trial Information
Comparison of Two-versus Three-Dimensional Treatment Planning for Patients Receiving Chest Radiotherapy for Symptom Control
Standard RT planning will be performed under conventional simulation, followed by
CT-simulation (for study purposes only). Retrospectively, 3D treatment fields will be
designed using the CT-simulation data, and compared to the actual treatment fields planned
using x-rays. Coverage of the tumour volume will be assessed, together with doses, field
sizes and beam positions, to determine relative undercoverage of tumour and overcoverage of
normal tissue between the two planning methods, if any.
Inclusion Criteria:
- Patients with local symptoms secondary to histologically-confirmed non-small cell
lung cancer
- Patients who will be receiving palliative-intent external beam radiotherapy
- Patients who are clinically appropriate for conventional radiotherapy planning
- Patients who can provide written informed consent
Exclusion Criteria:
- Patients who cannot provide written informed consent
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Cross-Sectional
Principal Investigator
Dr. Alysa Fairchild, MD FRCPC
Investigator Role:
Principal Investigator
Investigator Affiliation:
Alberta Health Services
Authority:
Canada: Health Canada
Study ID:
24639
NCT ID:
NCT00862030
Start Date:
April 2009
Completion Date:
January 2011
Related Keywords:
- Non-Small Cell Lung Cancer
- Palliative radiotherapy
- Treatment planning
- Non-small cell lung cancer
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
Name | Location |
|---|
